Chemoinformaics analysis of 2-Butenoic-Acid-Lactone
| Molecular Weight | 410.472 | nRot | 0 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 37 |
| Exact Molecular Weight | 410.131 | nRing | 7 |
| Solubility: LogS | -9.482 | nHRing | 1 |
| Solubility: LogP | 7.426 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 7 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 6 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 30 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 36 |
| nHA | 2 | APOL | 63.7063 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.188 |
| Synth | 2.35 |
| Natural Product Likeliness | 0.42 |
| NR-PPAR-gamma | 0.866 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.105 |
| Pgp-sub | 0.463 |
| HIA | 0.469 |
| CACO-2 | -4.996 |
| MDCK | 0.0000201 |
| BBB | 0.021 |
| PPB | 0.926835 |
| VDSS | 0.415 |
| FU | 0.0072529 |
| CYP1A2-inh | 0.879 |
| CYP1A2-sub | 0.212 |
| CYP2c19-inh | 0.726 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.429 |
| CYP2c9-sub | 0.939 |
| CYP2d6-inh | 0.12 |
| CYP2d6-sub | 0.928 |
| CYP3a4-inh | 0.137 |
| CYP3a4-sub | 0.056 |
| CL | 4.192 |
| T12 | 0.053 |
| hERG | 0.058 |
| Ames | 0.77 |
| ROA | 0.093 |
| SkinSen | 0.973 |
| Carcinogencity | 0.938 |
| EI | 0.987 |
| Respiratory | 0.76 |
| NR-Aromatase | 0.841 |
| Antiviral | No |
| Prediction | 0.592882 |